Enheten för Kliniska Studier (EKS), Örebro

Örebro 703 62

0 studies enrolling now · 2 studies all time

What they study most

Diabetes Mellitus, Type 2, Obesity, Overweight

Studies at this site

• A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Weekly Semaglutide (COMBINE 2) — Completed
• Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity — Completed